chr8-86214620-TG-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_138817.3(SLC7A13):c.1205delC(p.Thr402fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000107 in 1,609,620 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00058 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000058 ( 0 hom. )
Consequence
SLC7A13
NM_138817.3 frameshift
NM_138817.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.947
Genes affected
SLC7A13 (HGNC:23092): (solute carrier family 7 member 13) Predicted to enable L-amino acid transmembrane transporter activity. Predicted to be involved in L-cystine transport; L-glutamate transmembrane transport; and aspartate transmembrane transport. Predicted to be integral component of membrane. Predicted to be active in apical plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC7A13 | NM_138817.3 | c.1205delC | p.Thr402fs | frameshift_variant | 4/4 | ENST00000297524.8 | NP_620172.2 | |
SLC7A13 | XM_011516867.3 | c.1178delC | p.Thr393fs | frameshift_variant | 4/4 | XP_011515169.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC7A13 | ENST00000297524.8 | c.1205delC | p.Thr402fs | frameshift_variant | 4/4 | 1 | NM_138817.3 | ENSP00000297524.3 | ||
SLC7A13 | ENST00000419776.2 | c.*4delC | 3_prime_UTR_variant | 5/5 | 1 | ENSP00000410982.2 |
Frequencies
GnomAD3 genomes AF: 0.000578 AC: 88AN: 152206Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
88
AN:
152206
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000130 AC: 32AN: 246026Hom.: 0 AF XY: 0.0000751 AC XY: 10AN XY: 133230
GnomAD3 exomes
AF:
AC:
32
AN:
246026
Hom.:
AF XY:
AC XY:
10
AN XY:
133230
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000583 AC: 85AN: 1457296Hom.: 0 Cov.: 31 AF XY: 0.0000524 AC XY: 38AN XY: 724812
GnomAD4 exome
AF:
AC:
85
AN:
1457296
Hom.:
Cov.:
31
AF XY:
AC XY:
38
AN XY:
724812
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000578 AC: 88AN: 152324Hom.: 0 Cov.: 33 AF XY: 0.000577 AC XY: 43AN XY: 74490
GnomAD4 genome
AF:
AC:
88
AN:
152324
Hom.:
Cov.:
33
AF XY:
AC XY:
43
AN XY:
74490
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 10, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This variant has not been reported in the literature in individuals affected with SLC7A13-related conditions. This variant is present in population databases (rs754097389, gnomAD 0.2%), and has an allele count higher than expected for a pathogenic variant. This sequence change creates a premature translational stop signal (p.Thr402Lysfs*2) in the SLC7A13 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 69 amino acid(s) of the SLC7A13 protein. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AL_spliceai
Position offset: 26
Find out detailed SpliceAI scores and Pangolin per-transcript scores at